1,166
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Risk factors for BK virus infection in living-donor renal transplant recipients: a single-center study from China

, , , , , , & show all
Pages 442-446 | Received 19 Jul 2017, Accepted 10 Jun 2018, Published online: 27 Jul 2018

References

  • Gardner SD, Field AM, Coleman DV, et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971;297:1253–1257.
  • Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30:209–217.
  • Egli A, Infanti L, Dumoulin A. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199:837–846.
  • Vigil D, Konstantinov NK, Barry M, et al. BK nephropathy in the native kidneys of patients with organ transplants: clinical spectrum of BK infection. World J Transplant. 2016;6:472–504.
  • Hirsch HH, Randhawa P. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):179–188.
  • Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant. 2005;5:1926–1933.
  • Dekeyser M, François Hélène, Beaudreuil Séverine, et al. Polyomavirus-specific cellular immunity: from BK-virus-specific cellular immunity to BK-virus-associated nephropathy. Front Immunol. 2015;6:307.
  • Pai D, Mann DM, Malik A, et al. Risk factors for the development of BK virus nephropathy in renal transplant recipients. Transplant Proc. 2015;47:2465–2469.
  • Costa C, Cavallo R. Polyomavirus-associated nephropathy. World J Transplant. 2012;2:84–94.
  • Pollara CP, Corbellini S, Chiappini S, et al. Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVAN. New Microbiol. 2011;34:165–171.
  • Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013;13:136–145.
  • Jamboti JS. BK virus nephropathy in renal transplant recipients. Nephrology (Carlton). 2016;21:647–654.
  • Pham PT, Schaenman J, Pham PC. BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions. Curr Opin Organ Transplant. 2014;19:401–412.
  • Velioglu A, Aksu B, Asicioglu E, et al. Association of BK virus titers with lymphocyte count in renal transplant patients. Transplant Proc. 2015;47:1421–1424.
  • Hirsch HH, Yakhontova K, Lu M, et al. BK polyomavirus replication in renal tubular epithelial cells is inhibited by Sirolimus, but activated by Tacrolimus through a pathway involving FKBP-12. Am J Transplant. 2016;16:821–832.
  • Borni-Duval C, Caillard S, Olagne J, et al. Risk factors for BK virus infection in the era of therapeutic drug monitoring. Transplantation 2013;95:1498–1505.
  • Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347:488–496.
  • Awadalla Y, Randhawa P, Ruppert K, et al. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant. 2004;4:1691–1696.